Avexima Information

JSC Avexima is a Russian full-cycle pharmaceutical company. The company is one of the leading manufacturers not only of innovative drugs, but also of well-established, effective, affordable, high-quality medicines for treating various diseases. Today the company's portfolio includes over 120 medicinal products from various pharmacotherapeutic groups in areas such as urology, gynecology, neurology, cardiology, endocrinology, gastroenterology and others. Many of them are included in the Vital and Essential Drugs (VED) list. The production division of Avexima includes several modern pharmaceutical plants: Avexima Siberia LLC (Anzhero-Sudzhensk, Kemerovo Region), Irbit Chemical Pharmaceutical Plant JSC (Irbit, Sverdlovsk Region), Immapharma LLC (Moscow). Thanks to its own production base, Avexima is one of the few unique pharmaceutical manufacturers, since it not only produces finished dosage forms but also synthesizes their basis — the active pharmaceutical ingredient (API). The entire drug manufacturing process undergoes rigorous quality control in modern laboratory facilities equipped at all of the company's plants. Avexima is actively expanding its R&D capabilities for new drug development. The modern Avexima R&D center in the Skolkovo Technopark is one of the most advanced research centers in the country. This allows us not only to improve the quality and enhance the effectiveness of the company's existing products, but also to create new drugs for treating today's most pressing health challenges. Modern production, the advancement of scientific research in pharmacology, and high professionalism of our employees enable us to create modern, high-quality, and affordable medicines for consumers and to strengthen the foundation of the country's pharmaceutical security. Contacts info@avexima.pro